Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Cocaine and Alcohol Dependence
NCT00167232Phase 3Completed
- Sponsor
- University of Pennsylvania
- Start
- Jan 1998
- Primary completion
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol dependence and cocaine dependence comparing Naltrexone 150mg/day with Placebo Sugar Pill (2 arms). Primary endpoints: Prevention of Alcohol Relapse and Safety and Tolerability. Started Jan 1998; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol dependencecocaine dependence
Beyond the preview
Go deeper on NCT00167232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00167232.